Literature DB >> 30454909

Childhood serotonergic function and early adult outcomes in youth with ADHD: A 15-year follow-up study.

Iliyan Ivanov1, Janine Flory2, Jeffrey H Newcorn2, Jeffrey M Halperin3.   

Abstract

Longitudinal studies have shown that clinical precursors of antisocial personality disorder (ASPD) include attention-deficit/hyperactivity disorder (ADHD) and more notably comorbid ADHD and conduct disorder (CD). Despite existing evidence for the purported role of abnormal serotonergic function in aggressive youth and adults, little evidence exists on the role of serotonin in the progression from childhood disruptive behavior disorders to adult psychopathology, including ASPD. This study examined the relation between serotonergic function in children diagnosed with ADHD and the development of ASPD in early adulthood. We hypothesized that low serotonin response to a pharmacological probe in childhood would predict the development of adult ASPD. Towards this goal we divided 40 adults (M = 37, F = 3), ages 23-26 (m-24.57, sd-2.33) diagnosed with childhood ADHD into 2 groups: participants with (n = 21) and without (n = 19) ASPD. We used logistic regression to assess whether serotonergic measures in childhood assessed via prolactin and cortisol responses to a fenfluramine challenge, would selectively predict the development of ASPD in early adulthood. Logistic regression models showed that low central serotonergic response in childhood indexed by cortisol response significantly predicted adult ASPD (Wald = 4.427, p = .035) but not ADHD diagnosis in adulthood. Adults without ASPD had the highest serotonergic response whereas adults with adolescent ASPD (i.e. early onset ASPD) had the lowest response. Thus we provide new evidence of the link between low serotonergic function in childhood and the development of ASPD in adulthood, particularly for boys with adolescent onset of ASPD. These findings are relevant for understanding the contribution of childhood neurobiology to risk for later ASPD.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  ADHD; Antisocial personality disorder (ASPD); aggression; fenfluramine challenge; prolactin; serotonergic function

Mesh:

Substances:

Year:  2018        PMID: 30454909      PMCID: PMC6296770          DOI: 10.1016/j.euroneuro.2018.09.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  48 in total

1.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

Review 2.  Advances in biomarkers of major depressive disorder.

Authors:  Tiao-Lai Huang; Chin-Chuen Lin
Journal:  Adv Clin Chem       Date:  2015-01-07       Impact factor: 5.394

3.  Elevated childhood serotonergic function protects against adolescent aggression in disruptive boys.

Authors:  Jeffrey M Halperin; Jessica H Kalmar; Kurt P Schulz; David J Marks; Vanshdeep Sharma; Jeffrey H Newcorn
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-07       Impact factor: 8.829

4.  Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents.

Authors:  M J Kruesi; J L Rapoport; S Hamburger; E Hibbs; W Z Potter; M Lenane; G L Brown
Journal:  Arch Gen Psychiatry       Date:  1990-05

5.  Antisocial behaviors moderate the deviant peer pathway to substance use in children with ADHD.

Authors:  Michael P Marshal; Brooke S G Molina
Journal:  J Clin Child Adolesc Psychol       Date:  2006-06

6.  Serotonin, aggression, and parental psychopathology in children with attention-deficit hyperactivity disorder.

Authors:  J M Halperin; J H Newcorn; I Kopstein; K E McKay; S T Schwartz; L J Siever; V Sharma
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-10       Impact factor: 8.829

7.  Test-retest reliability of the prolactin and cortisol responses to D,L-fenfluramine challenge in disruptive behavior disorders.

Authors:  D M Stoff; A P Pasatiempo; J H Yeung; W H Bridger; H Rabinovich
Journal:  Psychiatry Res       Date:  1992-04       Impact factor: 3.222

8.  Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample.

Authors:  S B Manuck; J D Flory; J M McCaffery; K A Matthews; J J Mann; M F Muldoon
Journal:  Neuropsychopharmacology       Date:  1998-10       Impact factor: 7.853

9.  Socioeconomic status and psychiatric disorders: the causation-selection issue.

Authors:  B P Dohrenwend; I Levav; P E Shrout; S Schwartz; G Naveh; B G Link; A E Skodol; A Stueve
Journal:  Science       Date:  1992-02-21       Impact factor: 47.728

10.  Neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents.

Authors:  D M Stoff; A P Pasatiempo; J Yeung; T B Cooper; W H Bridger; H Rabinovich
Journal:  Psychiatry Res       Date:  1992-09       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.